Ubrelvy starts working within about 1 to 1.5 hours, with the drug reaching its peak concentration in your bloodstream around that time. Most people notice meaningful pain relief by the 2-hour mark. In clinical trials, roughly 61% to 63% of patients reported pain relief within 2 hours of taking a dose, compared to about 48% to 49% of those who took a placebo.
What Happens in the First Two Hours
After you swallow an Ubrelvy tablet, the active ingredient (ubrogepant) is absorbed quickly. Blood levels begin climbing within minutes, and median peak concentrations occur somewhere between 40 minutes and 1.5 hours, depending on the individual. That rapid absorption is why some people feel relief before the full 2-hour window.
The 2-hour mark is the standard benchmark used in migraine trials because it captures a clear snapshot of drug performance. At that point, both the 50 mg and 100 mg doses performed similarly in studies. In one large trial, 60.7% of patients on 50 mg and 61.4% on 100 mg had pain relief at 2 hours. A second trial found 62.7% relief with 50 mg. Both doses significantly outperformed placebo.
Relief here means a reduction from moderate or severe pain to mild or no pain. Complete pain freedom, where the headache disappears entirely, happens for a smaller percentage of people at 2 hours but continues to improve over the following hours as the drug stays active in your system.
How Long the Effects Last
Ubrelvy has an elimination half-life of approximately 5 to 7 hours, meaning it takes that long for half the drug to clear your body. In practical terms, a single dose provides meaningful activity for several hours after you take it. This is why the drug can continue reducing pain and associated symptoms well past the initial 2-hour window.
If the first dose doesn’t provide enough relief, you can take a second dose at least 2 hours after the first. The maximum allowed in a 24-hour period is 200 mg total. So if you start with 50 mg, you could take another 50 mg (or step up, depending on your prescription) after that 2-hour minimum gap.
Taking It Early Makes a Difference
Timing matters more than most people realize. A Phase 3 trial called PRODROME tested what happens when patients take Ubrelvy during the early warning phase of a migraine, 1 to 6 hours before headache pain actually begins. Many migraine sufferers recognize this phase: fatigue, mood changes, neck stiffness, food cravings, or light sensitivity that signal a headache is coming.
The results were striking. When patients took Ubrelvy during the prodrome, 46% avoided developing moderate or severe headache within 24 hours, compared to 29% on placebo. Nearly a quarter (24%) avoided headache of any intensity entirely within 24 hours. Patients who treated early also had significantly better functional ability, meaning they could go about their day more normally.
The takeaway is straightforward: if you can recognize your migraine building and take Ubrelvy before the pain ramps up, you have a better chance of heading it off or keeping it mild.
Factors That May Affect Timing
Individual variation plays a role in how fast you feel relief. The wide range of peak blood levels (anywhere from 40 minutes to 1.5 hours) reflects real differences in absorption speed between people. Factors like your metabolism, hydration, and whether your stomach is full or empty can all shift the timeline slightly. Ubrelvy can be taken with or without food, so you don’t need to worry about eating first during an attack.
How far along your migraine is when you take the medication also matters. As the PRODROME trial showed, early dosing improves outcomes. Waiting until pain is severe and fully established gives the drug more ground to make up, and you may feel like it’s working more slowly even though the absorption rate is the same.
What to Expect Realistically
Ubrelvy is not an instant fix. If you’re used to injectable migraine medications that work in 10 to 15 minutes, an oral tablet that peaks around 1 to 1.5 hours will feel slower by comparison. But for an oral medication, the onset is relatively fast, and the relief tends to build steadily rather than hitting all at once.
It also won’t work for everyone every time. In the clinical trials, about 37% to 39% of patients on Ubrelvy did not achieve pain relief at 2 hours. That doesn’t necessarily mean the drug failed completely for those individuals. Some experienced partial improvement, and others may have seen relief develop after the 2-hour measurement point. But if you consistently find that Ubrelvy isn’t providing adequate relief, that’s worth discussing with whoever manages your migraine treatment. Having realistic expectations going in helps: plan for about 1 to 2 hours before you feel a noticeable difference, and take it as early in the attack as possible.